In both organs, the direct consequences of the AT1 receptor upregulation involves the over-stimulation of the profibrotic cytokine transforming growth factor-β, which seems to orchestrate the development and progression of diabetes-associated hepatic fibrosis and nephropathy [53]. Here, AGTR1 is linked to kidney disorder.